|
|||||
|
|
Circulating tumor cells as a potential efficacy end point in clinical trials of hormone-resistant prostate cancer |
|
| Authors: | Samir S. Taneja |
| Affiliation: | (1) Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy;(2) Unit of Laboratory Medicine, European Institute of Oncology, Milan, Italy;(3) Department of Statistics, University of Milan-Bicocca, Milan, Italy;(4) Division of Medical Oncology, European Institute of Oncology, Milan, Italy;(5) Division of Pathology, European Institute of Oncology, Milan, Italy |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |